Table 1 Clinical- and treatment-related characteristics of HIV-infected adults on HAART at the University of Gondar comprehensive specialized referral hospital

Duration since HIV confirmed (year)

1–4

47 (14.5)

5–10

187 (57.9)

> 10

89 (27.6)

Past opportunistic infection at enrollment

Yes

84 (26)

No

239 (74)

Duration from enrollment to eligibility (year)

≥ 1

31 (9.6)

< 1

292 (90.4)

Baseline WHO stage

Stages I and II

88 (27.3)

Stage III

191 (59.1)

Stage IV

44 (13.6)

Duration since ART initiation (year)

1–5

97 (30)

6–10

151 (46.8)

> 10

75 (23.2)

Baseline BMI (kg/m²)

< 18.5

139 (43)

≥ 18.5

184 (57)

TB treatment history at enrollment

Yes

33 (10.2)

No

290 (89.8)

Reasons for eligibility

Clinical

16 (5)

CD4 count

188 (58.2)

Total lymphocyte count

1 (0.3)

Transfer in

2 (0.6)

Test and treat

7 (2.2)

Clinical and CD4 count

109 (33.7)

Any medication other than ART

Yes

74 (22.9)

No

249 (77.1)

Baseline BMI (kg/m²)

< 18.5

139 (43)

≥ 18.5

184 (57)

Baseline anemic status

Anemic

76 (23.5)

Non-anemic

247 (76.5)

Baseline CD4 count (cell/mm³)

< 200

176 (54.5)

200–499

111 (34.4)

> 499

36 (11.1)

Baseline functional status

Working

277 (85.8)

Ambulatory and bedridden

46 (14.2)

BMI at VL testing (kg/m²)

< 18.5

58 (18)

≥ 18.5

265 (82)

CD4 at VL testing (cell/mm³)

< 350

106 (32.8)

350–499

66 (20.4)

> 499

151 (46.8)